Marker Therapeutics, Inc. Gains 34.44%

Fri, Mar 19, 2021 at 05:30 PM
Marker Therapeutics, Inc. Gains 34.44%

Marker Therapeutics, Inc. (MRKR:NASDAQ) shot up at $2.42, a gain of 34.4%. On Thu 18 Mar 21, MRKR:NASDAQ touched a New 2-Week Low of $1.8. The stock got featured on our News Catalysts scanner on Tue 16 Mar 21 at 05:18 PM in the 'PUBLIC OFFERING' category. From Thu 04 Mar 21, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Tue 09 Feb 21 at $3.77 with a volume of 2M+.

About Marker Therapeutics, Inc. (MRKR:NASDAQ)

TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.